by Jordana Choucair | Jun 1, 2022 | Public Health/Prevention
The House Judiciary Committee announced it will markup a gun control package on Thursday. The “Protecting Our Kids Act” includes proposals that would raise the age limit to purchase some semi-automatic rifles to 21 years old, establish a federal ban on new...
by Jordana Choucair | May 31, 2022 | Life Sciences
Next week a key Food and Drug Administration (FDA) advisory committee will examine Novavax’s application for an emergency use authorization for its COVID-19 vaccine for adults 18 and older. Novavax originally planned to ask FDA for authorization by May 2021 but...
by Jordana Choucair | May 31, 2022 | Life Sciences
British drugmaker GSK PLC will buy vaccine manufacturer Affinivax Inc. for up to $3.3 billion, giving it access to promising experimental vaccine technology that targets two dozen common diseases. A GSK executive said Affinivax’s technology could broaden...
by Jordana Choucair | May 31, 2022 | Payers
Health and Human Services (HHS) Secretary Xavier Becerra announced on Friday that the Centers for Medicare & Medicaid Services (CMS) will not lower Medicare premiums for adults 65 and over until 2023. The adjustment is intended to compensate for...
by Jordana Choucair | May 31, 2022 | Public Health/Prevention
The World Health Organization (WHO) characterized monkeypox as a “moderate” public health risk as the illness spreads to varying geographical locations. The WHO said that since May 26, a total of 257 laboratory-confirmed cases have been reported across the globe....
Recent Comments